Thus, either loss of Fbxl8 or gain of a cyclin D3 mutation that stabilizes cyclin D3 protein level will accelerate cell cycle progression and lymphoma cell growth consistent Fbxl8 functioning as a tumor suppressor (Fig. 7d). The gene discussed is FBXL8; the disease is neoplasm.